Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

Survey finds adults with type 2 diabetes were very willing to see their physicians and other medical professionals more often.

New skin cancer combination therapy more effective than current treatments.

New testing procedure can quickly evaluate HIV levels in the blood.

Mouth cancer rates show significant increase among males and females of all ages.

A commonly used food additive can cause low-grade gut inflammation that leads to colon carcinogenesis.

Proton pump inhibitors and histamine receptor-2 blockers have damaging effects on the kidneys.

Approximately 12,000 first strokes could be prevented through optimal drug prescribing.

Newly developed technology maps HIV inserts across the human genome.

Distinct subsets of synovial fibroblasts in rheumatoid arthritis development identified.

A diagnostic diabetes breathalyzer may one day become a reality.

Study captures major changes in infectious diseases between 1980 through 2014.

New treatments show promise harnessing the immune system to attack late-stage skin cancer.

A newly developed hand-held breath analyzer tests for elevated levels of acetone, which is strongly associated with undiagnosed diabetes.

Top news of the day from across the health care landscape.

A first-of-its-kind study successfully transferred an ovary from one individual to another.

New progress made towards the development of an HIV vaccine.

A novel drug used in combination with radiation found to be a more effective treatment for prostate cancer.

About 1 in 6 women diagnosed with breast cancer have a symptom other than a lump.

The rubella virus stays in the body of patients with severe deficiencies in their immune defenses, making them more susceptible to side effects.

Top news of the day from across the health care landscape.

Launch of South Africa-based clinical trial provides hope for the defeat of HIV.

Study precisely maps the location of disease causing mutations.

Top news of the day from across the health care landscape.

Tailored dose-dense chemotherapy did not statistically improve recurrence-free survival in breast cancer patients.

Higher incidence of chromosomal polymorphisms in infertile individuals.

Zepatier shows promise across genotypes 1 and 4, even among patients administered opioid agonist therapy.

Baricitinib is a once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of autoimmune and inflammatory diseases.

A more personalized surveillance approach may help catch melanomas in high-risk patients.

Discovery may help regulate B lymphocytes and lead to new treatments for systemic lupus erythematosus.